Lisinopril Sandoz

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Lisinopril Sandoz

Quick Facts

Property Description
Active ingredient Lisinopril
Form Oral Tablet
Pharmacological class Angiotensin-Converting Enzyme (ACE) Inhibitor
General purpose Lowering of blood pressure
Origin Synthetic Compound

What Type of Medication is Lisinopril Sandoz?

Lisinopril Sandoz is a prescription medication supplied as an oral tablet, whose function is based on the active ingredient, Lisinopril. It is classified as an Angiotensin-Converting Enzyme (ACE) Inhibitor, placing it within a family of cardiovascular agents clinically recognized for their role in managing conditions related to blood vessel pressure. Lisinopril is a synthetic compound and is designed as a single-ingredient product, differing from combination drugs that include a second therapeutic agent.

Lisinopril Sandoz: Composition and Chemical Properties

The therapeutic action is derived entirely from Lisinopril, which is chemically distinguished by its non-sulfhydryl structure, a feature that contributes to its duration of action and chemical stability. This oral preparation is supported by inactive excipients necessary for the tablet's integrity and consistent release. This composition ensures that the patient receives a precise, measured dose of the active ACE inhibitor compound.

What is the General Purpose of an ACE Inhibitor?

The general purpose of a medication belonging to the ACE Inhibitor class is to achieve sustained control over blood pressure by promoting the relaxation of blood vessels. Lisinopril achieves this by blocking a key enzyme, thereby stopping the production of a powerful chemical that causes arteries to narrow. This action facilitates vasodilation, which decreases the resistance to blood flow and supports the reduction of blood pressure. This fundamental function defines its role as a core agent for cardiovascular management.

Regulatory References

  1. ACE Inhibitors - MedlinePlus

What side effects are possible with Lisinopril Sandoz?

Possible Side Effects and Safety Information

The safety profile for Lisinopril is officially documented by government regulatory bodies and categorizes adverse reactions based on their frequency and the system they affect. This information is presented at a high, non-instructional level.

Officially Classified Adverse Reactions

The following are classified by regulatory frequency standards, such as those used by the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA):

Classification Example Adverse Reactions (SOC Group)
Common (may affect up to 1 in 10 people) Dizziness, headache (Nervous System); dry cough (Respiratory); fatigue (General Disorders).
Uncommon (may affect up to 1 in 100 people) Mood alterations, vertigo (Nervous System); palpitations (Cardiac Disorders); rash (Skin).
Rare (may affect up to 1 in 1,000 people) Angioedema (swelling of face, throat); Acute Renal Failure (Renal); Hepatic Failure (Hepatobiliary).

Serious Safety Constraints

Angioedema, involving swelling of the face, tongue, or larynx, is explicitly highlighted as a serious adverse reaction, even though it is classified as rare. Severe reactions such as Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) are also documented safety concerns. Due to the mechanism of action, official labeling requires the monitoring of serum potassium and renal function because of the potential for electrolyte imbalance and changes in kidney status.

Time- and Population-Related Patterns

Specific safety patterns are noted: symptomatic hypotension (a drop in blood pressure) is documented as being more likely to occur after the initial dose or following a dose increase. A persistent dry cough is officially associated with long-term exposure to the medicine. Furthermore, special monitoring is required for patients with renal impairment, and the medicine is generally contraindicated in those with a history of hereditary or idiopathic angioedema.

Overdose and Emergency Response

Overdose and when to seek help

Overdose with Lisinopril is primarily defined by an exaggerated pharmacological effect, presenting as profound hypotension, a severe drop in blood pressure, and bradycardia, an abnormally slow heart rate. These presentations may result in symptoms such as dizziness, lightheadedness, or syncope (fainting). Regulatory documents note the potential for life-threatening outcomes, including acute renal failure and severe electrolyte imbalance, specifically hyperkalemia. Secondary events such as myocardial infarction or cerebrovascular accident may also occur in susceptible individuals due to the excessive hypotension.

Immediate medical attention is required for any suspected overdose. Official guidance mandates contacting emergency services immediately if the affected individual has collapsed, experienced a seizure, or is unresponsive. All symptomatic or hypotensive patients require hospital monitoring, including frequent checks of vital signs, serum electrolytes, and renal function.

No specific antidote for Lisinopril overdose is known. Management is symptomatic and supportive, utilizing measures such as intravenous fluid administration to restore blood pressure. Procedural steps, including the use of activated charcoal for recent large ingestions or haemodialysis for refractory cases, are documented. Additionally, exposure during the second or third trimester is officially linked to foetotoxicity and neonatal toxicity.

Therapeutic Uses of Lisinopril Sandoz

Lisinopril Sandoz is commonly used in the management of conditions marked by increased physiological stress in the cardiovascular domain. Its primary role is considered relevant to provide supportive benefits that assist with maintaining functional stability and contribute to an improved sense of well-being. This medicine is commonly used across three core therapeutic areas: high blood pressure (hypertension), heart failure, and assistance following a heart attack.

Lisinopril Sandoz plays a role in managing these conditions. It helps patients cope more steadily with symptom fluctuations and is applied in scenarios where additional symptomatic support is needed. For those with high blood pressure, it supports general well-being during symptomatic phases. In heart failure, it provides supportive relief in contexts involving heightened systemic burden.

“This medication is applied in clinical settings that involve acute or unstable symptom patterns and often assists with maintaining functional stability.”

Quick Fact: Supports Management of Systemic Imbalance

Lisinopril Sandoz is commonly used to help address symptoms related to systemic imbalance and heightened physiological activity, contributing to improved comfort during periods of heightened symptoms.

Eligibility and Restrictions for Use

Who can and cannot use Lisinopril Sandoz?

The population eligibility for Lisinopril Sandoz is defined by specific regulatory contraindications and age-related limitations.

Absolute Contraindications

Use of this medicine is strictly contraindicated for several populations:

  • Patients with a history of angioedema (swelling) related to previous treatment with any ACE inhibitor or those with hereditary or idiopathic angioedema.
  • Patients with known hypersensitivity to Lisinopril, any excipient, or any other ACE inhibitor.
  • Patients using a neprilysin inhibitor (e.g., sacubitril) or within 36 hours of the last dose.
  • Patients with Diabetes Mellitus or certain types of renal impairment who are also taking Aliskiren.
  • Pregnant women during the second and third trimesters; the medicine must be discontinued as soon as possible if pregnancy is detected.

Age and Physiological Limitations

Lisinopril Sandoz is not recommended for children younger than 6 years of age. For pediatric patients ge 6 years old, use is established only for hypertension and requires adequate kidney function ( GFR ge 30 mL/min/1.73 m^2). The medicine is not recommended for use while breastfeeding.

What should I know about interactions with other medicines?

Lisinopril can interact with various other medicines and product categories, which may affect its action or increase the risk of specific side effects.

Contraindicated Combinations

  • Neprilysin (NEP) Inhibitors: Medications such as Sacubitril/valsartan must not be taken concurrently. A separation period of at least 36 hours is required when switching between Lisinopril and a NEP inhibitor to avoid a heightened risk of angioedema (severe swelling of the face, tongue, or throat).
  • Aliskiren: Co-administration is contraindicated in patients with diabetes or moderate-to-severe kidney impairment due to the increased risk of low blood pressure, high potassium levels, and worsening kidney function.

Major Interaction Categories

  • Potassium-Elevating Agents: The risk of hyperkalemia (high blood potassium) is significantly increased when Lisinopril is combined with potassium-sparing diuretics (e.g., spironolactone, amiloride), potassium supplements, or potassium-containing salt substitutes. Close monitoring is necessary.
  • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): NSAIDs, including selective COX-2 inhibitors, may reduce the blood pressure-lowering effect of Lisinopril and increase the risk of developing or worsening kidney problems, particularly in older patients, those taking diuretics, or those with existing kidney impairment.
  • Lithium: Lisinopril may reduce the excretion of lithium, leading to increased lithium levels and potential toxicity. Serum lithium concentration requires regular monitoring.
  • Other Antihypertensive Agents/Diuretics: Concomitant use with other blood pressure medications or diuretics may cause an excessive drop in blood pressure (hypotension).
  • Antidiabetic Agents: Lisinopril may increase the blood sugar-lowering effect of insulin and oral antidiabetics, increasing the risk of hypoglycemia (low blood sugar).

Mechanism of Action

Lisinopril Sandoz functions as a competitive inhibitor of the somatic form of Angiotensin-Converting Enzyme (ACE), designated as kininase II.

ACE is a zinc metallopeptidase primarily anchored to the luminal surface of endothelial cells, particularly those lining the pulmonary vasculature and renal arterioles. Lisinopril structurally mimics the C-terminal dipeptide of its endogenous substrate, Angiotensin I, binding with high affinity to the active catalytic site of ACE. This interaction prevents the enzyme from executing its primary function: the conversion of the decapeptide Angiotensin I into the potent octapeptide vasoconstrictor, Angiotensin II.

The resulting molecular and intracellular consequence is a dose-dependent reduction in circulating and local tissue levels of Angiotensin II. This downstream cascade leads to decreased AT1 receptor activation and aldosterone secretion from the adrenal cortex. Additionally, ACE inhibition impedes the degradation of bradykinin, an endogenous vasodilator, contributing to its accumulation. The system-level physiological consequences include vasodilation of both efferent and afferent arterioles, decreased vascular resistance, and increased renal sodium and water excretion.

Dosage and Administration Information

How to Use Lisinopril Sandoz

Lisinopril Sandoz tablets must be used exactly as prescribed by a healthcare professional. These instructions summarize the official guidelines for administration, dosage, and procedure.


Administration and Dosage Rules

Guideline Official Instruction
Route Administered orally (by mouth).
Frequency Taken once a day.
Timing Should be taken at about the same time each day to maintain consistent effects.
With Food May be taken with or without food.

Procedural Steps

The tablets should be swallowed whole with a full glass of water. They must not be crushed, split, or chewed, unless specifically instructed by a pharmacist or physician.

Therapy is initiated by the physician using a low dose, which may be gradually increased depending on the patient's condition and response to treatment. Patients must continue taking the medicine for the entire duration prescribed by their doctor, as it controls the condition but does not cure it.


Handling Missed Doses

If a dose is missed, take it as soon as it is remembered. However, if it is almost time for the next scheduled dose, the missed dose must be skipped. Patients must not take a double dose to compensate for a forgotten one.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Lisinopril Sandoz

This section describes the research that has been conducted on Lisinopril Sandoz and the lisinopril compound, focusing on the structures and findings observed in clinical studies. This is not clinical advice, and study results reflect group patterns, not personal outcomes.

Evidence for Lisinopril Sandoz Use in High Blood Pressure (Hypertension)

Research on lisinopril's use in hypertension primarily involved large-scale Randomized Controlled Trials (RCTs). These studies explored how blood pressure measurements change over time, monitoring outcomes like the later occurrence of strokes or heart attacks. Studies reported measurements of lower blood pressure over short-term and intermediate follow-up periods when compared to control groups. Some research highlights changes measured during the study period related to a pattern of lower incidence of major cardiovascular events.

The evidence base for this use includes multiple large RCTs, but comparative evidence is lacking for the specific long-term outcomes of Lisinopril Sandoz versus every other available generic lisinopril product. Additionally, data for certain groups remain insufficient, especially regarding long-term measured outcomes for patients with very specific, complex forms of hypertension.

Evidence for Lisinopril Sandoz Use in Heart Failure

Extensive placebo-controlled RCTs and comparative trials were used in research exploring how symptoms change over time in patients with heart failure. Research describes patterns where treatment was associated with measurements of lower mortality rates and a reduced number of hospitalizations related to heart failure exacerbation when compared to a placebo group over multi-year follow-up periods. Other studies report how symptoms evolved, sometimes showing a stabilization or reported changes in patient-reported outcomes.

There is limited information for long-term outcomes specifically in patients who have heart failure with a preserved ejection fraction (HFpEF), as the main body of evidence focused on reduced ejection fraction (HFrEF) populations. The certainty remains low regarding the measured benefits when the drug is initiated at very low doses versus higher doses, as findings were mixed on hard endpoints like all-cause mortality.

Key Studies & References

  1. GISSI-3: Effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction

Frequently Asked Questions (FAQ)

Common questions about Lisinopril Sandoz (FAQ)


Q: Does Lisinopril Sandoz actually treat heart failure or only manage the symptoms?

Lisinopril is officially described as adjunctive therapy for the treatment of heart failure. This means it is used alongside other measures to help the condition. It works by reducing blood pressure and other physical stresses placed on the heart.


Q: What is the typical time of day for taking Lisinopril Sandoz?

Official guidelines state that Lisinopril Sandoz must be taken once daily at about the same time each day to maintain consistent effects. The product information does not specify a 'typical' time, like morning or evening, as long as the timing is consistent.


Q: Is it common to feel dizzy or lightheaded when first starting Lisinopril Sandoz?

Yes, regulatory documents list dizziness as a common side effect. Additionally, the possibility of symptomatic hypotension (a drop in blood pressure causing symptoms like lightheadedness) is a known effect, often occurring after the initial dose or following a dose increase.


Q: How long does the dry cough side effect from Lisinopril Sandoz usually last?

The persistent dry cough is a common side effect for some patients on this type of medication. Official reports indicate the cough typically begins within months of starting therapy. Regulatory-cited data indicates that the cough generally resolves within one to four weeks after the medication is discontinued, though individual recovery times can vary.


Q: What are the signs of the serious side effect called angioedema with Lisinopril Sandoz?

Angioedema, which is severe swelling, is a rare but serious adverse reaction noted in official labeling. Signs include rapid swelling of the face, extremities, lips, tongue, and/or larynx. Involvement of the tongue or larynx is a serious concern because it may lead to airway obstruction.


Q: Does Lisinopril Sandoz affect blood sugar levels, especially for people with diabetes?

Official product information notes that if Lisinopril is taken with insulin or other oral antidiabetic medications, it may increase the effectiveness of these medications. This action increases the potential risk of hypoglycemia (low blood sugar).


Q: Can taking Lisinopril Sandoz cause a change in potassium levels?

Yes, Lisinopril can cause a small increase in serum potassium (blood potassium) levels, known as hyperkalemia. This change is generally not significant for most people but is a factor that requires monitoring, especially when the drug is combined with other agents that also affect potassium.


Q: Are there any common over-the-counter pain relievers that should be avoided with Lisinopril Sandoz?

Yes, Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), a class that includes many common over-the-counter pain relievers, may interact with Lisinopril. This combination may reduce the medicine's blood pressure-lowering effect and increase the potential risk of developing or worsening kidney problems.


Q: What is the main risk if Lisinopril Sandoz is taken during pregnancy?

The use of Lisinopril during the second and third trimesters of pregnancy carries a high risk of causing injury and potentially death to the developing fetus. Possible fetal outcomes include prematurity, restricted growth, and specific cardiovascular defects.


Q: Can men experience sexual side effects, such as erectile dysfunction, while taking Lisinopril Sandoz?

Official labeling mentions impotence in the list of adverse reactions. This effect is not described as common. If this or any other potential side effect is noted, consulting a healthcare provider is the appropriate action.


Q: Does Lisinopril Sandoz cause weight gain or weight loss?

Regulatory documents indicate that Lisinopril does not lead to measurable weight gain or weight loss in clinical studies. Any changes in weight observed are typically related to other factors, such as fluid retention or the underlying heart condition being treated.


Q: Is it safe to drink alcohol in moderation while taking Lisinopril Sandoz?

Official information states that alcohol and Lisinopril may have additive effects in lowering blood pressure. This combined action can increase the risk of symptoms like headache, dizziness, or lightheadedness, particularly when treatment is first started.


Q: Why are routine blood tests necessary when taking Lisinopril Sandoz?

Routine blood tests are a mandatory monitoring requirement listed in official warnings. They are necessary to check serum potassium and renal function because of the potential for the drug to cause an electrolyte imbalance or changes in the status of the kidneys.


Q: What is the difference between Lisinopril Sandoz and a combination pill like Lisinopril/HCTZ?

Lisinopril Sandoz is defined as a single-ingredient product, meaning it contains only the active ingredient lisinopril. Combination pills, such as those with HCTZ, contain lisinopril plus a second active ingredient, which is typically a diuretic (water pill).


Q: Why is dehydration a concern when taking Lisinopril Sandoz in hot weather or during exercise?

The drug's blood pressure-lowering effect can be amplified in situations that cause volume or sodium depletion, such as severe sweating during hot weather or exercise. This change increases the potential risk of developing symptomatic hypotension (a drop in blood pressure causing symptoms).


Q: What are the potential signs of liver problems linked to Lisinopril Sandoz?

While rare, liver problems, including hepatic failure, have been reported in post-marketing experience. Signs that may suggest a liver issue include jaundice (yellowing of the skin or eyes) and unusual fatigue.


Q: How does Lisinopril Sandoz affect the kidney’s function to protect it?

Official indications confirm that Lisinopril is used to slow the rate of progression of kidney disease in certain patients with high blood pressure and Type 2 diabetes. Its action on the renin-angiotensin system supports kidney function.


Q: What are the typical long-term side effects that official documents mention for Lisinopril Sandoz?

A persistent dry cough is specifically associated with long-term exposure to the medicine. Other common effects, such as dizziness and fatigue, may also continue during chronic treatment.


Q: Does the risk of side effects from Lisinopril Sandoz change based on age?

Yes, official documents indicate that age is a factor. Pediatric use is restricted to certain ages and conditions, and there is a noted higher risk of kidney problems when used with NSAIDs, particularly in older patients.


Q: What are the non-active ingredients used in Lisinopril Sandoz tablets?

The active ingredient is Lisinopril, which is supported by inactive excipients. These ingredients are necessary to give the tablet its form and ensure the consistent release of the medicine. The specific list is available in the official product description on the drug label.


Q: Can Lisinopril Sandoz cause new or worsened joint pain or muscle aches?

Rare adverse effects noted in post-marketing experience include a symptom complex that may involve arthralgia (joint pain) and myalgia (muscle aches/pain). This indicates that such symptoms have been reported but are not common.


Q: Can Lisinopril Sandoz be used for long-term management after a heart attack?

Official documents indicate that Lisinopril is indicated for the treatment of hemodynamically stable patients within 24 hours of an acute myocardial infarction (heart attack). Dosing for this specific condition is typically continued for at least 6 weeks.


Q: Does Lisinopril Sandoz have a known effect on sleep, like insomnia or strange dreams?

Official labeling mentions insomnia (trouble sleeping) as a rare adverse reaction associated with the medication. Other types of sleep disturbances are not explicitly listed.


Q: Can Lisinopril Sandoz cause a change in the sense of taste?

Yes, the official adverse reactions list includes reports of taste disturbances.


Q: Is it true that patients with low blood pressure might not be able to take Lisinopril Sandoz?

Official warnings state that Lisinopril therapy should be administered cautiously in patients with or predisposed to hypotension (low blood pressure). This is because of the risk of causing or worsening symptomatic low blood pressure.


Q: Are there any known interactions between Lisinopril Sandoz and common foods or juices?

Official guidelines recommend that patients avoid a moderately high or high potassium dietary intake while taking the medicine. However, specific common foods or juices are not listed as presenting an interaction risk.


Q: Can Lisinopril Sandoz cause cold or flu-like symptoms?

Official labeling mentions adverse reactions including body aches or pain, chills, fever, sore throat, and rhinitis (runny nose). These symptoms are reported and can resemble cold or flu symptoms.


Q: Can Lisinopril Sandoz make someone more sensitive to the sun?

Yes, the adverse reactions list documented by regulatory bodies includes photosensitivity. This means the drug may potentially cause increased sensitivity to sunlight or UV light.


Q: Does the side effect of blurred vision from Lisinopril Sandoz require immediate medical attention?

Official labeling lists blurred vision as a less common side effect. The occurrence of any adverse reaction, including blurred vision, is information a healthcare provider should be aware of.


Q: Is there a link between Lisinopril Sandoz and problems with the eyes, such as yellowing?

Yes, yellowing of the skin or eyes (jaundice) is listed as a potential sign related to possible liver problems. Jaundice is a rare but serious adverse reaction that has been documented in association with the drug.

How should Lisinopril Sandoz be stored and disposed of?

How to Store and Dispose of Lisinopril Sandoz

The storage and disposal of lisinopril tablets must adhere strictly to official regulatory guidelines to maintain product stability and ensure safety.


Official Storage Requirements

Condition Requirement
Temperature Store at Controlled Room Temperature (20 C to 25 C). Brief excursions are permitted up to 30 C.
Protection The container must be tight and light-resistant, and the tablets must be protected from moisture.
Child Safety The medication must be kept out of the reach and sight of children at all times.

Disposal

Expired or unused lisinopril product must be disposed of in accordance with local requirements. If no take-back program is available, official guidance advises against disposal in wastewater (flushing). The medication should be mixed with an undesirable substance, sealed, and placed into the household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Lisinopril Sandoz found in:

A-Z Index: